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Acronyms
LBW- Low Birth Weight
SGA- Small for Gestational Age
IUGR-Intrauterine Growth Retardation
Introduction
Caffeine (1,3,7-trimethylxanthine) is a naturally occurring com-
pound. Its pharmacological and physiological effects include 
stimulation of the central nervous system and cardiac muscle, 
and relaxation of smooth muscle. Caffeine has been shown to 
have effects on physical and cognitive performance, as well as 
mood, memory, and alertness. Caffeine is the most widely used 
stimulant for the central nervous system. Clinically, caffeine is 
useful for relaxing the bronchial muscle in asthmatic patients, 
increasing secretion of gastric acid, and the concentrations of 
plasma free fatty acids, and glucose (Institute of Medicine, 2001).
Sources of Caffeine
Coffee, tea, and soft drinks are the main sources of caffeine in 
the diet of the average American adult. Other dietary sources 
include chocolate and cocoa, sugars and sweets, and flavored 
dairy products. Tea also contains a significant amount of theoph-
ylline (1,3-dimethylxanthine), as cocoa also contains theobro-
mine (3,7-dimethylxanthine), both being derivatives of caffeine 
that have not been as widely researched (Frary, 2005). Many 
classes of nonprescription medications including analgesics, 
cold/allergy products, diuretic products, stimulants, and weight 
control agents have some caffeine content. All medications have 
a suggested dose, but consistent usage may lead to the medi-
cation becoming a significant source of caffeine consumption.
Absorption, Distribution, and Elimination of Caffeine 
Absorption
Caffeine and the other methylxanthines are quickly absorbed in 
humans. As much as 99 percent is absorbed within the 45 minutes 
after ingestion. Oral, rectal, and parenteral administration is possi-
ble, with the oral route being most common. When consumed in a 
beverage, the caffeine is quickly absorbed from the gastrointestinal 
tract and distributed throughout body water. Caffeine in prepara-
tions that allow absorption through oral mucosa, such as caffein-
ated chewing gum, are absorbed even more rapidly. Depending 
on the source of the caffeine and the individual’s metabolism, 
caffeine’s peak plasma levels appear between 15 and 120 minutes 
after ingestion or administration (Institute of Medicine, 2001).
Distribution
The distribution volume of caffeine within the body is 0.7 L/
kg, demonstrating caffeine’s hydrophilic quality and ability to 
distribute freely into intracellular tissue water (Arnaud, 1993). 
Caffeine can also pass through all biological membranes and 
freely crosses the blood-brain barrier, demonstrating its lipo-
philic quality (Institute of Medicine, 2001). In pregnant women, 
the caffeine can cross the placenta to the fetus, and as early as 
7-8 weeks gestation, maternal and fetal plasma can achieve an 
equilibrium (Goldstein, Warren, 1962). A fetus swallows approx-
imately 500 mL of amniotic fluid daily, and studies suggest that 
several milligrams of caffeine can be ingested along with the 
fluids. Additionally, by week 12 of gestation the fetal liver is able 
to methylate theophylline to caffeine (Brazier, 1981). Both caf-
feine and theophylline are eliminated in the amniotic fluid, with 
caffeine’s fetal elimination half-life at approximately 150 hours, 
while theophylline’s is 30 hours.
Elimination
The small fraction of caffeine that is excreted unchanged in 
urine indicates that caffeine metabolism is the rate-limiting fac-
tor in its plasma clearance. Its limited appearance in urine is due 
to caffeine being readily reabsorbed by the renal tubules and fil-
tered by the glomeruli (Arnaud, 1993). Frequent caffeine inges-
tion has not been shown to affect its absorption or metabolism 
in healthy humans. The bulk of caffeine metabolism takes place 
in the liver, catalyzed by hepatic microsomal enzyme systems 
(Grant et. al., 1987). In the liver, caffeine is metabolized to di-
methylxanthines, uric acids, di- and trimethylallantoin, and uracil 
derivatives. 3-ethyl demethylation to paraxanthine is shown to 
be the most frequent route for caffeine metabolism in humans 
(Arnaud, 1987). This is the first step in caffeine metabolism and 
accounts for approximately 75–80 percent of the process. Being 
the chief metabolite in humans, paraxanthine is found to have a 
plasma concentration ten times higher than those of theophyl-
line and theobromine. Eight to ten hours after ingestion, plasma 
levels of paraxanthine surpass those of caffeine, as caffeine is 
cleared more rapidly than paraxanthine (Arnaud, 1993). During 
the second and third trimesters of pregnancy, maternal caf-
feine elimination rates drop due to changes in progesterone 
and estrogen levels, with the half-life of caffeine changing from 
5.3 hours to 18.1 hours. Maternal clearance of caffeine during 
pregnancy can be decreased further by other factors, including 
smoking and long-term use of oral contraceptives, as well as age 
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and disease. Within a couple of weeks of giving birth, a women’s 
caffeine metabolism rate returns to the same rate as prior to 
pregnancy (Aldridge et. al., 1981).
Methods
Critical analysis of peer reviewed journal articles and original 
clinical research papers was used to write this review. The ar-
ticles and papers were obtained with access to online publica-
tions through the Touro College library. Additional references 
were obtained through Pubmed and Google Scholar.
Effects of Caffeine Consumption on Birth Weight
A low birth weight (LBW) infant is one who weighs less than 
2,500 g (5 lbs, 8 oz) at birth. Prematurity due to a shortened 
gestational period can cause low birth weight, but LBW can 
also be the consequence of intrauterine growth retardation 
(IUGR), which results in a small for gestational age (SGA) in-
fant. Intrauterine growth retardation is classified as less than 
the 10th percentile of birth weight for gestational age in com-
parison to an external standard of birth weight for gestational 
age, adjusted for gender and ethnicity, that was developed from 
all 1999 singleton births in the United States, and updated in 
2014 (Talge et. al., 2014). Many studies have shown a strong cor-
relation between caffeine intake during pregnancy and reduced 
birth weights. For pregnant women who consume more than 
300 mg of caffeine daily, a high risk of SGA and IUGR has been 
found. Intake between 150 mg and 300 mg daily has also been 
linked to such risks; however, the data is not as consistent.  
From 2003-2006, a perspective cohort study following preg-
nant women between the ages of 18 and 45 with singleton preg-
nancies was implemented. The caffeine intake of these women 
was monitored, and the relationship between caffeine and fetal 
growth was evaluated. At any level of caffeine intake there was 
an associated risk of fetal growth retardation found, and this risk 
was maintained throughout pregnancy. They found that after 
adjustment for smoking and alcohol intake, an average caffeine 
consumption of more than 100 mg per day was correlated with 
a reduction in birth weight of 34-59 g in the first trimester, 
24-74 g in the second, and 66-89 g in the third. An extra 60-70 g 
may seem insignificant, but it can make all the difference for an 
already compromised fetus, and can help avoid perinatal mor-
bidity and mortality. The study did observe a large decline in 
risk for a daily caffeine intake of less than 30 mg, but this may be 
due to unmeasured confounding, or simply because lower caf-
feine intake is probably more common among women who have 
healthier diets and habits in general (CARE Study Group, 2008).
A second prospective study observed the caffeine intake of 
9,921 healthy pregnant women throughout their third trimester. 
Fifty-three of the women reportedly consumed more than five 
cups of coffee daily, and they were found to have a 13.2% higher 
prevalence of fetuses who were SGA (Fuhurhashi et. al., 1985).
The Norwegian Mother and Child Cohort Study conducted 
by the Norwegian Institute of Public Health followed 59,123 
women with uncomplicated singleton pregnancies. At weeks 17, 
22, and 30, the women reported their caffeine intakes from dif-
ferent sources. SGA was defined according to ultrasound-based, 
population-based, and customized growth curves. Based on the 
three scales, an average of 25 g weight reduction was associated 
with every additional 100 mg of maternal caffeine intake per day 
for a baby with an expected birth weight of 3,600 g. Coinciding 
results for caffeine sources, time of survey, and different defi-
nitions of SGA were found for this, substantiating its results. 
Even caffeine consumption below the recommended maximum 
such as 200 mg per day, compared to the recommended 300 mg 
per day, was consistently associated with increased risk for SGA 
(Sengpiel, 2013).
Gestational age was not linked to caffeine intake in these 
studies, suggesting that the effect maternal caffeine consump-
tion has on fetal birth weight occurs through IUGR. Possible 
mechanisms responsible for this effect include caffeine’s similar 
structure to adenine and guanine which may allow it to interfere 
with cell division and metabolism. Additionally, caffeine has a va-
soconstrictive effect on placental intervillous blood flow, which 
may be a factor to increase the risk of IUGR (Kirkinen, 1983). 
During the first trimester of pregnancy, the embryo first 
starts developing its organs, heartbeat, brain waves, and the 
rest of its body parts. As this is such a crucial time of develop-
ment, caffeine intake should be limited especially then. In fact, a 
greater reduction in risk for IUGR and delivering LBW infants 
was found among women who reduced their caffeine intake to 
less than 300 mg within 6 days of their last menstrual period, 
compared to those who reduced their intake later in pregnancy 
(Fenster et. al., 1991).
There is a steady negative correlation between LBW infants 
and daily maternal caffeine intake above 300 mg. In many studies, 
a daily caffeine consumption between 151 and 300 mg, and oc-
casionally even 150 mg or lower has been associated with risks 
of low birth weight. Pregnant women should be sure to limit 
their caffeine intake as much as possible to lessen the proba-
bility of reductions in infant birth weight. The seemingly slight 
decrease in weight can be very harmful for premature infants 
or infants who are otherwise compromised.  Further research 
is needed to clarify the mechanisms by which caffeine exercises 
an effect on fetal growth.
Effects of Caffeine Consumption on Preterm 
Labor and Delivery
Caffeine has not been found to be a strong factor in increas-
ing the risks of preterm labor and delivery. In 1996–2000, 
2,291 mothers with singleton pregnancies in Connecticut 
and Massachusetts were questioned about caffeine consump-
tion and other important confounding factors after their first 
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prenatal visit. Urine samples were taken to analyze urinary caf-
feine, cotinine, and creatinine levels. The mothers were followed 
throughout pregnancy to monitor changes in consumption, 
and medical records were obtained to confirm pregnancy out-
comes. While mean birth weight was found to be reduced by 28 
g per 100 mg of daily caffeine intake, mean gestational age was 
not found to be affected at all (CARE Study Group, 2008).
In the Norwegian Mother and Child Cohort Study, sponta-
neous preterm delivery was defined as “spontaneous onset of 
delivery between 22+0 and 36+6 weeks (n = 1,451)”. Caffeine 
from coffee, but not from other sources, was actually associated 
with prolonged gestation, but no association of increased risk 
of spontaneous preterm delivery was found with caffeine con-
sumption (Sengpeil et. al., 2013).
Other studies as well found no effect on gestational age, indi-
cating that caffeine influences fetal growth, not gestational age 
at delivery. Pastor et. al performed a case control study of 408 
preterm (less than 37 weeks gestation) infants, and analysis of 
caffeine intake in the third trimester showed a nonsignificant 
relationship with preterm delivery (Pastore, Savotz, 1995). 
Alternatively, in a population-based study of 7,855 livebirths, 
increased preterm birth among women who drank caffeinated 
coffee was found compared with women who drank neither 
decaffeinated nor caffeinated coffee. Those who consumed only 
decaffeinated coffee showed no increased odds of SGA birth, 
LBW, or preterm delivery, while women who consumed caffein-
ated coffee alone had a higher association with preterm deliv-
ery (Eskenzai et. al., 1999). This study has not been replicated, 
and other analyses did not support it. 
Gestational age is difficult to calculate and assess, making 
this topic more difficult to analyze accurately. Generally, there 
appears to be no relationship between caffeine consumption 
during pregnancy and premature labor and delivery in humans. 
Effects of Caffeine Consumption on Spontaneous 
Abortion
Most studies report effects of caffeine on spontaneous abortion, 
however, there are some who suggest otherwise. In one study, 
2,967 pregnant women who delivered at Yale-New Haven hos-
pital between 1988 and 1992 were evaluated for caffeine intake 
during the first month of pregnancy. After studying the effect 
of the caffeine on pregnancy outcomes, it was concluded that 
increased risk of spontaneous abortions was linked to drinking 
more than 3 cups of tea or coffee daily. The association of risk 
with tea and coffee intake was shown to be stronger than with 
caffeine in general, and was primarily correlated with abortions 
which took place in later trimesters (Dlugosz et. al.,1996).
A prospective cohort study of 3,135 pregnant women found 
that those who consumed more than 151 mg of caffeine daily 
were more likely to spontaneously abort in the second or third 
trimester, in comparison to those who had a daily intake of less 
than 150 mg of caffeine (Srisuphan, Bracken, 1986). 
A study of healthy, pregnant women, all of whom were be-
yond 24 weeks of gestation revealed that caffeine consumption 
of more than 600 mg daily was significantly associated with 
impending abortion, with a higher prevalence of 17% found 
(Fuhurhashi et. al.,1985). 
Another study of 1,324 women demonstrated associations 
between caffeine intake prior to and during pregnancy with 
spontaneous abortions in 331 of the 1,324 women. The risk of 
fetal loss increased for each 100 mg of caffeine ingested daily 
during pregnancy, as well as smaller increases in risk for each 
100 mg of caffeine ingested daily prior to becoming pregnant 
(Infante-Rivard, 1993). 
Dominguez-Rojas et. al conducted a retrospective cohort 
study of 711 pregnant women, monitoring their caffeine intake, 
and found caffeine to be a clear risk factor for spontaneous 
abortion. They determined that the adjusted odds ratio (a mea-
sure of association between exposure and outcome) of spon-
taneous abortion by caffeine consumption was significant for 
141-280 mg daily, doubled for 281-420 mg daily, and then almost 
tripled for intake of greater than 421 mg daily (Dominguez-
Rojas et. al., 1994).
Alternatively, different studies found no association between 
maternal caffeine intake and spontaneous abortions. Four hun-
dred and thirty-one women were enrolled in a multicenter study 
within 21 days of conception. Throughout pregnancy, they were 
monitored for caffeine intake, and exposure to other risk factors, 
and the effects on pregnancy outcome. The investigators found no 
connection between caffeine intake, neither above or below 30 
mg daily, and increased risk of spontaneous abortions (Mills, 1993).
Determining a definite causal connection between caffeine 
intake and occurrence of spontaneous abortions is difficult, 
as many of the studies that have been done did not control 
properly for other factors such as smoking, parity, or alcohol 
intake. There seems to be a strong association between caffeine 
consumption and fetal loss, but more research must be done 
before unambiguous statements can be made. 
Effects of Caffeine Consumption on Congenital 
Malformations
Caffeine can perhaps act as a teratogen due to its chemical 
structure as a purine, one of the components of DNA. After 
maternal consumption, caffeine can cross the placenta to the 
developing embryo. If the molecule were to become incorpo-
rated into DNA, there is a possibility that it could induce the 
production of abnormal proteins (Goldstein, 1962). The liter-
ature reviewed showed no significant evidence linking human 
maternal caffeine intake during pregnancy to major congenital 
malformations. 
In a study performed to analyze information from the Finnish 
Registry of Congenital Malformation, mothers who had given 
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birth to infants with the same defects were matched according 
to place and time of birth. One mother in each pair consumed 
coffee during pregnancy, while the other did not. To evaluate the 
hypothesis that coffee consumption during pregnancy is terato-
genic, the 706 pairs of mothers of malformed children and their 
controls were interviewed soon after delivery. The subjects of 
the study included 112 mothers of children with defects of the 
central nervous system, 241 mothers of children with orofacial 
clefts, 210 mothers of children with structural defects of the 
skeleton, and 143 mothers of children with cardiovascular mal-
formations. The study determined that coffee intake does not 
appear to increase risk for any of the defects that were studied. 
Even mothers who consumed more than six cups of coffee per 
day had no higher risk of giving birth to an infant with congen-
ital malformations. The study also paired these mothers with 
women who gave birth to non-defective infants, in the same 
time and place, and who consumed an equivalent amount of 
caffeine daily during pregnancy. The amount of coffee consumed 
during pregnancy was similar for the mothers of malformed 
and non-malformed children, with the broad range of maternal 
intake being 0-10 cups daily, demonstrating that excessive cof-
fee intake does not increase risk of congenital malformations 
(Kurppa et. al., 1983). 
Mcdonald et al. investigated the relationships between smok-
ing, alcohol intake, and caffeine consumption, and congenital 
malformations using data from a survey conducted in Montreal 
from 1982-1984. A weak association between caffeine con-
sumption and heart defects was found, but the evidence was 
not strong. There was no connection found between caffeine 
intake and club foot, clefts, neural tube defects, or musculoskel-
etal renal/urinary, gastrointestinal, or respiratory abnormalities 
(Mcdonald et al., 1992). 
Similarly, a study was performed to determine the possible ef-
fects of different chemical and physical factors during pregnancy 
on the occurrence of cardiovascular malformations, specifically 
hypoplastic left heart syndrome.  Using a standard questionnaire, 
573 cases and 1,055 controls were interviewed approximately 3 
months after delivery. An increased risk of cardiovascular mal-
formations was not found to be associated with coffee, tea, or 
cola consumption (Tikkanen, Heinonen, 1994)
One study did show an increased risk for malformations due 
to caffeine. A retrospective case-control study was executed in 
which 558 women in England who had delivered an anenceph-
alic stillbirth were matched with 2,232 control women based 
on maternal age, parity, and date of delivery. Based on a struc-
tured questionnaire completed by the cases and controls, it was 
shown that the women who drank 3 or more cups of tea daily 
were more likely to give birth an anencephalic stillborn (Fedrick, 
1974). However, the results of this study may not be completely 
accurate, and the authors themselves wrote that caution should 
be taken when interpreting their results.
Most studies agree that there is no connection between caf-
feine intake during pregnancy and congenital abnormalities. Any 
connections that were found have been deemed weak at best. 
Conclusion
Maternal caffeine intake during pregnancy should be limited to 
between 150 mg and 300 mg per day, to mitigate negative effect 
caffeine has been shown to have on birth weight, risk of IUGR, 
and risk of spontaneous abortion. More studies must be done 
to confirm correlation between caffeine and spontaneous abor-
tion, and based on current data, there does not seem to be a 
significant risk of preterm labor or congenital malformations 
related to caffeine intake. 
Pregnancy is a time when motherly instincts begin to kick 
in, and women are likely to be receptive to counseling about 
lifestyle changes. Many women are unaware of the real risk that 
their caffeine intake can create for their unborn child. Doctors 
and prenatal counselors should be sure to discuss the matter 
with soon-to-be mothers so they can make informed decisions 
when consuming caffeine during pregnancy. In addition, having a 
health care provider monitor caffeine intake may help establish 
the degree of risk for use of other drugs or high-risk behaviors 
during pregnancy.
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